Enliven Therapeutics
ELVN
#5218
Rank
NZ$1.95 B
Marketcap
$41.28
Share price
5.84%
Change (1 day)
80.91%
Change (1 year)

Enliven Therapeutics (ELVN) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$0.49 B

According to Enliven Therapeutics's latest financial reports the company has NZ$0.49 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enliven Therapeutics - Net assets on balance sheet (from 2021 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$0.38 B-421.35%
2022-12-31$-NZ$0.13 B93.22%
2021-12-31$-NZ$62.63 M121.82%
2020-12-31$-NZ$28.24 M